tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA

ANIP Stock Latest News

ANI Pharmaceuticals Reports Record Q1 2025 Results
Company AnnouncementsANI Pharmaceuticals Reports Record Q1 2025 Results
15h ago
ANIP
ANI Pharmaceuticals Reports Record Growth in Earnings Call
PremiumCompany Announcements
ANI Pharmaceuticals Reports Record Growth in Earnings Call
18h ago
ANIP
ANI Pharmaceuticals reports Q1 adjusted EPS $1.70 vs. $1.21 last year
PremiumThe Fly
ANI Pharmaceuticals reports Q1 adjusted EPS $1.70 vs. $1.21 last year
1d ago
ANIP
ANI Pharmaceuticals raises FY25 adj. EPS view to $6.27-$6.62 from $6.12-$6.49
PremiumThe Fly
ANI Pharmaceuticals raises FY25 adj. EPS view to $6.27-$6.62 from $6.12-$6.49
1d ago
ANIP
ANI Pharmaceuticals Files Proxy for 2025 Meeting
PremiumCompany Announcements
ANI Pharmaceuticals Files Proxy for 2025 Meeting
2d ago
8K
ANIP
ANIP Earnings Report this Week: Is It a Buy, Ahead of Earnings?
PremiumPre-EarningsANIP Earnings Report this Week: Is It a Buy, Ahead of Earnings?
3d ago
ANIP
ANI Pharmaceuticals presents preclinical data on use of Cortrophin Gel
Premium
The Fly
ANI Pharmaceuticals presents preclinical data on use of Cortrophin Gel
5d ago
ANIP
ANI Pharmaceuticals: Strategic Shift and Litigation Outcomes Poised to Drive Growth
Premium
Ratings
ANI Pharmaceuticals: Strategic Shift and Litigation Outcomes Poised to Drive Growth
11d ago
ANIP
ANI Pharmaceuticals price target raised to $65 from $62 at Truist
PremiumThe Fly
ANI Pharmaceuticals price target raised to $65 from $62 at Truist
19d ago
ANIP
ANI Pharmaceuticals: Strategic Growth and Stability Amid Market Uncertainties
PremiumRatings
ANI Pharmaceuticals: Strategic Growth and Stability Amid Market Uncertainties
1M ago
ANIP
Strong Growth and Undervaluation Make ANI Pharmaceuticals a Buy
PremiumRatings
Strong Growth and Undervaluation Make ANI Pharmaceuticals a Buy
2M ago
ANIP
ANI Pharmaceuticals launches Nitazoxanide Tablets, 500 mg.
PremiumThe Fly
ANI Pharmaceuticals launches Nitazoxanide Tablets, 500 mg.
2M ago
ANIP
ANI Pharmaceuticals announces royalty obligation buyout for Iluvien, Yutiq
PremiumThe FlyANI Pharmaceuticals announces royalty obligation buyout for Iluvien, Yutiq
2M ago
ANIP
Positive Outlook for ANI Pharmaceuticals: FDA Approval and Strategic Moves Drive Buy Rating
Premium
Ratings
Positive Outlook for ANI Pharmaceuticals: FDA Approval and Strategic Moves Drive Buy Rating
2M ago
ANIP
ANI Pharmaceuticals announces FDA approval for expansion of Iluvien label
Premium
The Fly
ANI Pharmaceuticals announces FDA approval for expansion of Iluvien label
2M ago
ANIP
ANI Pharmaceuticals initiated with a Buy at Jefferies
PremiumThe Fly
ANI Pharmaceuticals initiated with a Buy at Jefferies
2M ago
ANIP
ANI Pharmaceuticals initiated with an Overweight at JPMorgan
PremiumThe Fly
ANI Pharmaceuticals initiated with an Overweight at JPMorgan
2M ago
ANIP
ANI Pharmaceuticals Discusses Alimera Acquisition Challenges
PremiumCompany Announcements
ANI Pharmaceuticals Discusses Alimera Acquisition Challenges
2M ago
8K
ANIP
ANI Pharmaceuticals price target raised to $86 from $84 at Guggenheim
PremiumThe Fly
ANI Pharmaceuticals price target raised to $86 from $84 at Guggenheim
2M ago
ANIP
ANI Pharmaceuticals Reports Record 2024 Results and Raises 2025 Guidance
PremiumCompany AnnouncementsANI Pharmaceuticals Reports Record 2024 Results and Raises 2025 Guidance
2M ago
ANIP
Ani Pharmaceuticals’ Future Hinges on Ocumension’s Success with ILUVIEN in Asia-Pacific
Premium
Company Announcements
Ani Pharmaceuticals’ Future Hinges on Ocumension’s Success with ILUVIEN in Asia-Pacific
2M ago
ANIP
ANI Pharmaceuticals Reports Record Growth and Raises 2025 Outlook
Premium
Company Announcements
ANI Pharmaceuticals Reports Record Growth and Raises 2025 Outlook
2M ago
ANIP

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >